Evidence map›Paper›PMID 42045651›Full record

ArticleCommunications chemistry2026

Experimentally validated deep learning control of protein aggregation.

Vojtech Cima, Antonin Kunka, Joan Planas-Iglesias, Ekaterina Grakova, Martin Havlasek, Madhumalar Subramanian, Michal Beloch, Martin Marek, Katerina Slaninova, Jiri Damborsky and 3 more

Abstract read
In one paragraph

Article in Communications chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Vojtech Cima *IT4Innovations, VSB - Technical University of Ostrava, Ostrava-Poruba, Czech Republic.
Antonin Kunka *Loschmidt Laboratories, Department of Experimental Biology and RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.ORCID http://orcid.org/0000-0002-1170-165X
Joan Planas-IglesiasLoschmidt Laboratories, Department of Experimental Biology and RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.ORCID http://orcid.org/0000-0002-6279-2483
Ekaterina GrakovaIT4Innovations, VSB - Technical University of Ostrava, Ostrava-Poruba, Czech Republic.
Martin HavlasekLoschmidt Laboratories, Department of Experimental Biology and RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.
Madhumalar SubramanianLoschmidt Laboratories, Department of Experimental Biology and RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.
Michal BelochIT4Innovations, VSB - Technical University of Ostrava, Ostrava-Poruba, Czech Republic.ORCID http://orcid.org/0000-0001-7968-8917
Martin MarekLoschmidt Laboratories, Department of Experimental Biology and RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.ORCID http://orcid.org/0000-0001-7220-5644
Katerina SlaninovaIT4Innovations, VSB - Technical University of Ostrava, Ostrava-Poruba, Czech Republic.ORCID http://orcid.org/0000-0002-2520-7054
Jiri DamborskyLoschmidt Laboratories, Department of Experimental Biology and RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.ORCID http://orcid.org/0000-0002-7848-8216
Zbynek ProkopLoschmidt Laboratories, Department of Experimental Biology and RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic. zbynek@chemi.muni.cz.ORCID http://orcid.org/0000-0001-9358-4081
David BednarLoschmidt Laboratories, Department of Experimental Biology and RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic. 222755@mail.muni.cz.ORCID http://orcid.org/0000-0002-6803-0340
Jan MartinovicIT4Innovations, VSB - Technical University of Ostrava, Ostrava-Poruba, Czech Republic. jan.martinovic@vsb.cz.ORCID http://orcid.org/0000-0001-7944-8956

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 857560Grantová Agentura České Republiky (Grant Agency of the Czech Republic) GX25-17329XMinisterstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports) 90254Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports) LM2023042Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports) LM2023055Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports) MSCAfellow5_MUNI
6 · The paper itself

Abstract

The identification of aggregation-prone regions in proteins and their suppression through mutations is a powerful strategy to enhance protein solubility and yield, significantly expanding their potential applications. Here, we developed and experimentally validated a deep neural network-based predictor, AggreProt, that generates a residue-level aggregation profile for protein sequences. The model outperformed or matched current state-of-the-art algorithms, as validated on two independent datasets comprising hexapeptides and full-length proteins with annotated aggregation-prone regions. Importantly, we validated the model experimentally using a set of 34 hexapeptides identified in the model protein haloalkane dehalogenase LinB, along with seven proteins from the AmyPro database. Experimental results agreed with our predictions in 79% of cases and revealed inaccuracies in some database annotations. Finally, the algorithm's utility was demonstrated by identifying aggregation-prone regions in the LinB enzyme and designing mutations to suppress aggregation in its exposed regions. The resulting variants exhibited reduced aggregation propensity, improved solubility, and up to a 100% increase in yield compared to the wild type. AggreProt is freely available to the scientific community via a user-friendly web server: https://loschmidt.chemi.muni.cz/aggreprot .

Identifiers

PMID42045651
PMCPMC13328301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.